Trade Mark Journal No.2026/038 18 September 2026

WO0000001923494 (1,5,42,44)

Office of origin: Switzerland

Date of International Registration:24 March 2026
Date of designation in the UK: 24 March 2026
Image for mark 1923494

International priority date claimed: 17 October 2025 (Switzerland) (840135)
Class 1
Active chemical ingredients used in the manufacture of anti-cancer medicines and vaccines.
Class 5
Pharmaceutical products, substances and preparations, in particular for cancer treatment and prevention; medicinal preparations.
Class 42
Scientific services; scientific advice and information services; preparation of scientific reports; medical research; scientific research, in particular for cancer prevention and treatment.
Class 44
Medical services, in particular for cancer treatment and prevention; medical advice and information services; medical analysis services, in particular for cancer diagnosis and treatment; medical analysis of data; RNA or DNA analysis for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment.

Torpedo Pharmaceuticals AG

Representative: FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, Postfach, CH-3000 Bern 14, SWITZERLAND